Ropharma Bras
S.C. Ropharma S.A. operates a chain of pharmacies in Romania. The company distributes over-the-counter medications, food supplements, cosmetics, perfumery, medical devices, dermato-cosmetics, para pharmaceuticals, and other medicines through pharmaceutical warehouses. It also offers cardio-vascular, dermatological, digestive, ophthalmological, osteo-articular, respiratory, urogenital, and diabete… Read more
Ropharma Bras (RPH) - Total Assets
Latest total assets as of December 2024: RON947.76 Million RON
Based on the latest financial reports, Ropharma Bras (RPH) holds total assets worth RON947.76 Million RON as of December 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Ropharma Bras - Total Assets Trend (2021–2025)
This chart illustrates how Ropharma Bras’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Ropharma Bras - Asset Composition Analysis
Current Asset Composition (June 2025)
Ropharma Bras's total assets of RON947.76 Million consist of 63.5% current assets and 36.5% non-current assets.
| Asset Category | Amount (RON) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | RON0.00 | 2.1% |
| Accounts Receivable | RON320.34 Million | 33.8% |
| Inventory | RON226.09 Million | 23.9% |
| Property, Plant & Equipment | RON0.00 | 0.0% |
| Intangible Assets | RON36.20 Million | 3.8% |
| Goodwill | RON23.86 Million | 2.5% |
Asset Composition Trend (2021–2025)
This chart illustrates how Ropharma Bras's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ropharma Bras's current assets represent 63.5% of total assets in 2025, an increase from 43.3% in 2021.
- Cash Position: Cash and equivalents constituted 2.1% of total assets in 2025, up from 2.0% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 5.0% of total assets, a decrease from 6.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 33.8% of total assets.
Ropharma Bras Competitors by Total Assets
Key competitors of Ropharma Bras based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Cachet Pharmaceutical Co Ltd
SHE:002462
|
China | CN¥12.68 Billion |
|
Yunnan Hongxiang Yixintang
SHE:002727
|
China | CN¥15.84 Billion |
|
Luyan Pharma Co Ltd
SHE:002788
|
China | CN¥13.04 Billion |
|
Ji Yao Holding Group Co Ltd
SHE:300108
|
China | CN¥1.43 Billion |
|
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
SHE:300937
|
China | CN¥1.75 Billion |
|
ShuYu Civilian Pharmacy Corp. Ltd.
SHE:301017
|
China | CN¥9.84 Billion |
|
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
SHE:301126
|
China | CN¥6.56 Billion |
|
Anhui Huaren Health Pharmaceutical Co. Ltd. Cl A
SHE:301408
|
China | CN¥5.26 Billion |
Ropharma Bras - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Ropharma Bras generates 1.26x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Ropharma Bras is currently not profitable relative to its asset base.
Ropharma Bras - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.05 | 1.01 | 1.01 |
| Quick Ratio | 0.66 | 0.64 | 0.65 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | RON30.67 Million | RON 6.50 Million | RON 4.05 Million |
Ropharma Bras - Advanced Valuation Insights
This section examines the relationship between Ropharma Bras's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 17.3% |
| Total Assets | RON947.76 Million |
| Market Capitalization | $7.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ropharma Bras's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ropharma Bras's assets grew by 17.3% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ropharma Bras (2021–2025)
The table below shows the annual total assets of Ropharma Bras from 2021 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | RON947.76 Million | +17.33% |
| 2024-06-30 | RON807.78 Million | +4.87% |
| 2023-06-30 | RON770.25 Million | +80.25% |
| 2022-06-30 | RON427.32 Million | -0.74% |
| 2021-06-30 | RON430.53 Million | -- |